|
|
Article: Requip(R) (ropinirole HCl) Tablets Significantly Improve Symptoms of Restless Legs Syndrome (RLS) In Patients With RLS.
- Article from:
- PR Newswire
- Article date:
- January 3, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Largest U.S. Study in Moderate-to-Severe Primary RLS Published in Mayo Clinic Proceedings
RESEARCH TRIANGLE PARK, N.C., Jan. 3 /PRNewswire/ -- Data published in the January issue of Mayo Clinic Proceedings show that Requip(R) (ropinirole HCl) Tablets significantly improve RLS symptoms. The study, entitled TREAT RLS US (Therapy with Ropinirole, Efficacy and Tolerability in Restless Legs Syndrome), is the largest U.S. study to date of the treatment of Restless Legs Syndrome (RLS). The TREAT RLS US results support previous studies with Requip, the first and only FDA-approved treatment for moderate-to-severe primary RLS.
RLS is a chronic and disruptive ...